Sachin Phakey

MD, MPH, Hospital Medical Officer, Department of General Medicine, The Royal Melbourne Hospital, Melbourne, Vic

Impact of semaglutide and dulaglutide shortages on Pharmaceutical Benefits Scheme prescriptions supplied for type 2 diabetes treatment

This retrospective population-based study examines semaglutide and dulaglutide prescriptions for type 2 diabetes supplied via the Pharmaceutical Benefits Scheme from January 2021 to September 2022.